A former White House adviser who pushed malaria drugs as a treatment for COVID-19 long after the FDA had ruled them out has ...

The US Department of Health and Human Services said it will require that all new vaccines be tested in placebo-controlled ...

The US Department of Health and Human Services said Thursday that it aims to accomplish within four years a scientific feat ...

HHS implemented a pause on research of deadly infectious diseases at one of the nation's most highly secure research labs, ...

The U.S. Department of Health and Human services says it will require all new vaccines to be tested in placebo-controlled ...

In February, the HHS unexpectedly delivered notice that the South San Francisco-based company was to stop all work on the ...

The NIH plans to develop whole-virus vaccines that would provide universal immunity against all strains of influenza and COVID-19.

topping a previous award of $452 million to a company developing an experimental oral COVID-19 vaccine. An HHS spokesperson told CBS News that "decision-making for project Generation Gold Standard ...

While Vaxart can proceed with its study, fellow COVID-19 vaccine developers GeoVax and Novavax continue to be hamstrung by ...

Researchers aim to develop a universal vaccine platform that could protect against both COVID-19 and influenza without annual ...

A similar paradigm has unfolded for Covid-19 vaccines since they were first authorized in the height of the pandemic at the end of 2020. HHS’s new initiative also aims to develop universal ...